Unveiling the HER2-low phenomenon: exploring immunohistochemistry and gene expression to characterise HR-positive HER2-negative early breast cancerM. Gaudio, A. Zambelli, Armando Santoro et al.|Breast Cancer Research and Treatment|2023Cited by 9
53P HER2 low by immunohistochemistry (IHC) and gene expression by qRT-PCR using OncotypeDX in ER+ early breast cancerM. Gaudio, A. Zambelli, F. Jacobs et al.|ESMO Open|2023Cited by 1
RSC4All as a machine learning nomogram to predict RSClin™ results in HR+/HER2- node-negative early breast cancerFlavia Jacobs, Alberto Zambelli, Evandro de Azambuja et al.|ESMO Open|2025Cited by 0